Fishawack Health welcomes expert-led dermatology initiative FIDE to its groupKNUTSFORD, United Kingdom — Fishawack Health welcomes FIDE, an independent organization providing its clients with insight from clinical Share XFishawack Health welcomes expert-led dermatology initiative FIDE to its grouphttps://pharmaphorum.com/partner-content/fishawack-health-welcomes-expert-led-dermatology-initiative-fide-to-its-group/
Patient engagement strategies: the pharmaphorum podcastThis episode of the pharmaphorum podcast is the first in an occasional series focused on patient engagement that’s Share XPatient engagement strategies: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/patient-engagement-strategies
Amplifying the patient voice for better engagement, recruitment and retentionEveryone is familiar with the phrase ‘patient-centricity’ but, where it might once have been seen as a ‘checkbox Share XAmplifying the patient voice for better engagement, recruitment and retentionhttps://pharmaphorum.com/r-d/clinical-trials-patient-voice-prime-global/
Oncology R&D: the patient insights we’re still missing, and how to catch upImagine you are a pharma executive working in oncology R&D. The landscape is rapidly becoming more competitive and Share XOncology R&D: the patient insights we’re still missing, and how to catch uphttps://deep-dive.pharmaphorum.com/magazine/oncology-2021/oncology-rd-patient-engagement/
Why relationships are key in rare disease patient engagementReal-world data is a vital part of rare disease drug development, but to get a true picture of Share XWhy relationships are key in rare disease patient engagementhttps://pharmaphorum.com/views-and-analysis/why-relationships-are-key-in-rare-disease-patient-engagement/
Deep Dive: Market AccessIt’s fair to say this is the most interesting time ever for market access. Not only has COVID Share XDeep Dive: Market Accesshttps://pharmaphorum.com/views-analysis-market-access/deep-dive-market-access-2021/
Patient involvement in trial design: looking to the futureCOVID-19 has transformed the way we think about patient participation in trial design – but there are still Share XPatient involvement in trial design: looking to the futurehttps://pharmaphorum.com/patients/patient-involvement-in-trial-design-looking-to-the-future/
Deep Dive: Patients and PartnershipsAs this issue’s title suggests, patient centricity is about more than just talking points and marketing strategies – Share XDeep Dive: Patients and Partnershipshttps://pharmaphorum.com/views-analysis-patients/deep-dive-patients-and-partnerships/
3 steps for comprehensive patient collaborationJanssen’s Daniel de Schryver tells us why it’s time to give patients a permanent seat at the table Share X3 steps for comprehensive patient collaborationhttps://pharmaphorum.com/views-analysis-patients/3-steps-for-comprehensive-patient-collaboration/
